|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 161.60 EUR | -0.19% |
|
-3.35% | +35.80% |
| Aug. 04 | Marengo Therapeutics, Inc. and Ipsen S.A. Nominate First Drug Candidate Under Strategic Tristar Collaboration | CI |
| Aug. 03 | Jefferies Downgrades Ipsen to Underperform, Boosts PT | MT |
| Market Cap | 13.25B 15.32B 12.37B 11.35B 21.35B 1,458B 21.69B 145B 56.98B 731B 57.52B 56.26B 2,416B | P/E 2026 * |
13.4x | P/E 2027 * | 14.1x |
|---|---|---|---|---|---|
| Enterprise Value | 11.91B 13.77B 11.12B 10.2B 19.19B 1,310B 19.49B 130B 51.21B 657B 51.69B 50.56B 2,171B | EV / Sales 2026 * |
2.64x | EV / Sales 2027 * | 2.39x |
| Free-Float |
40.65% | Yield 2026 * |
0.95% | Yield 2027 * | 0.95% |
Last Transcript: Ipsen
| 1 day | -0.19% | ||
| 1 week | -3.35% | ||
| Current month | -3.35% | ||
| 1 month | -2.65% | ||
| 3 months | -2.88% | ||
| 6 months | +18.74% | ||
| Current year | +35.80% |
| 1 week | 153.1 |  | 165.2 |
| 1 month | 153.1 | | 174 |
| Current year | 116 | | 174 |
| 1 year | 105.6 | | 174 |
| 3 years | 87.95 | | 174 |
| 5 years | 77 | | 174 |
| 10 years | 34.2 | | 174 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Loew
CEO | Chief Executive Officer | 59 | 2020-06-30 |
| Chief Executive Officer | 57 | 2019-12-31 | |
Pierrick Lefranc
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Antoine Flochel
BRD | Director/Board Member | 61 | 2005-08-29 |
| Chairman | 68 | 2010-11-21 | |
Carol Xueref
BRD | Director/Board Member | 69 | 2012-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/25/26 | Sell | Chairman | 3,800 | 0.0045% | ||
| 5/29/25 | Fiscal year | Chief Executive Officer | 28,008 | 0.0334% | ||
| 3/13/25 | Sell | Chief Executive Officer | 2,000 | 0.0024% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.19% | -3.35% | +52.02% | +34.00% | 15.32B | |
| -0.52% | +3.21% | +89.52% | +127.32% | 1,057B | |
| +0.88% | +1.13% | +49.56% | +49.69% | 625B | |
| +0.89% | -1.95% | +24.23% | +64.44% | 435B | |
| +0.71% | +3.87% | +49.07% | +37.85% | 363B | |
| +0.64% | -0.49% | +33.94% | +40.01% | 296B | |
| +0.39% | -5.83% | +8.92% | +7.85% | 249B | |
| +1.51% | +6.69% | +42.58% | +57.57% | 222B | |
| +3.92% | -0.46% | -5.56% | -52.32% | 209B | |
| +1.80% | +2.30% | +11.56% | +66.35% | 165B | |
| Average | +1.00% | +0.44% | +35.58% | +43.28% | 363.61B | |
| Weighted average by Cap. | +0.65% | +1.20% | +48.74% | +64.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.5B 5.21B 4.21B 3.86B 7.26B 496B 7.37B 49.36B 19.37B 248B 19.56B 19.13B 821B | 4.58B 5.29B 4.28B 3.92B 7.38B 504B 7.49B 50.16B 19.69B 252B 19.88B 19.44B 835B |
| Net income | 1.01B 1.16B 940M 863M 1.62B 111B 1.65B 11.03B 4.33B 55.53B 4.37B 4.28B 184B | 968M 1.12B 904M 829M 1.56B 106B 1.58B 10.6B 4.16B 53.36B 4.2B 4.11B 176B |
| Net Debt | -1.34B -1.55B -1.25B -1.15B -2.16B -148B -2.2B -14.7B -5.77B -74B -5.83B -5.7B -245B | -2.32B -2.69B -2.17B -1.99B -3.74B -256B -3.8B -25.46B -9.99B -128B -10.09B -9.87B -424B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-07 | €161.60 | -0.19% | 107,122 |
| 26-08-06 | €161.90 | +1.38% | 108,916 |
| 26-08-05 | €159.70 | +1.78% | 98,502 |
| 26-08-04 | €156.90 | +2.48% | 127,698 |
| 26-08-03 | €153.10 | -8.43% | 150,980 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IPN Stock
Select your edition
All financial news and data tailored to specific country editions
